Cargando…
Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review
Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first approved by the US Food and Drug Administration in 2012. Despite correlations of decreases in new HIV infections being greatest where PrEP has been deployed, the uptake of PrEP is lagging, particularly among populat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467490/ https://www.ncbi.nlm.nih.gov/pubmed/32232664 http://dx.doi.org/10.1007/s12325-020-01295-0 |